Clinical Trials

New Search
Title   Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Disease/Condition   Blood and Bone Marrow Cancer,Pediatric Hematology/Oncology,Leukemia,Lymphoma,Lymphatic and Spleen Diseases,Neoplasms,Lymphoproliferative Disorders,Immune System Diseases
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Lisa Gennarini, MD
Contact Name   Annette Pedro
Contact Email
IRB/Protocol Number   2015-4852
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   Yes
Sub-Specialty   Acute Lymphoblastic Leukemia (ALL)